rosiglitazone has been researched along with Blastocyst Disintegration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; Hu, J; Li, M; Yao, L | 1 |
| Chrast, R; Desvergne, B; Joye, E; Mucciolo, A; Nadra, K; Quignodon, L; Sardella, C | 1 |
2 other study(ies) available for rosiglitazone and Blastocyst Disintegration
| Article | Year |
|---|---|
Decreased ANGPTL4 impairs endometrial angiogenesis during peri-implantation period in patients with recurrent implantation failure.
Topics: Adult; Angiopoietin-Like Protein 4; Cell Line; Decidua; Electric Impedance; Embryo Implantation; Embryo Loss; Embryo Transfer; Endometrium; Female; Fertilization in Vitro; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Physiologic; PPAR gamma; Pregnancy; Recurrence; Rosiglitazone; Sperm Injections, Intracytoplasmic; Stromal Cells; Uterine Artery; Young Adult | 2020 |
PPARgamma in placental angiogenesis.
Topics: Animals; Embryo Loss; Female; Gene Expression Regulation, Developmental; Germ Layers; Gestational Age; Glycoproteins; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Physiologic; Organ Specificity; Placenta; PPAR gamma; Pregnancy; Prolactin; Rosiglitazone; Thiazolidinediones | 2010 |